Primecap Management Co. CA reduced its position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 2.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,052,648 shares of the company’s stock after selling 214,773 shares during the period. […]
Christopher Paul German Sells 368 Shares of Rhythm Pharmaceuticals, Inc (NASDAQ:RYTM) Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Profund Advisors LLC trimmed its holdings in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 40.9% in the 3rd quarter, Holdings Channel reports. The firm owned 27,818 shares of the company’s stock after selling 19,262 shares during the quarter. Profund Advisors LLC’s holdings in Rhythm Pharmaceuticals were worth $638,000 at the end of […]
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) EVP Yann Mazabraud sold 1,594 shares of the company’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $51.38, for a total value of $81,899.72. Following the completion of the transaction, the executive vice president now directly owns 7,702 […]
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) CFO Hunter C. Smith sold 1,209 shares of the business’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $51.38, for a total transaction of $62,118.42. Following the transaction, the chief financial officer now directly owns 80,413 shares in […]